Diamorphine infusion in the preterm neonate

Area of Science:

• Neonatal pharmacology
• Pediatric critical care
• Pain management in neonates

Background:

• Premature neonates often require analgesia and sedation for medical procedures.
• Establishing safe and effective diamorphine (diacetylmorphine) dosing in this population is crucial.
• Understanding the pharmacokinetic and pharmacodynamic effects of diamorphine in neonates is essential.

Purpose of the Study:

• To evaluate the safety and efficacy of a specific diamorphine dosage regimen in premature neonates.
• To assess the physiological effects of diamorphine, including blood pressure, heart rate, and respiration.
• To determine plasma concentrations of morphine achieved with the studied diamorphine infusion.

Main Methods:

• A cohort of 34 premature neonates received a loading dose of 50 micrograms/kg followed by a continuous infusion of 15 micrograms/kg/hour of diamorphine.
• Hemodynamic parameters (blood pressure, heart rate) and respiratory rate were monitored post-administration.
• Plasma concentrations of morphine were measured at steady state during the infusion.

Main Results:

• Small, transient decreases in blood pressure and heart rate were observed, attributed to sedation, without clinical deterioration.
• A significant reduction in respiration rate occurred, facilitating synchronization with mechanical ventilation.
• Mean steady-state plasma morphine concentration was 62.5 (22.8) ng/ml, comparable to effective analgesic levels in older populations.

Conclusions:

• The studied diamorphine dosage regimen appears safe for premature neonates.
• The achieved plasma morphine concentrations suggest potential for effective analgesia.
• This regimen may aid in synchronizing infant breathing with ventilators, a critical aspect of neonatal care.